These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12708497)

  • 1. Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo.
    Morinaga Y; Suga Y; Ehara S; Harada K; Nihei Y; Suzuki M
    Cancer Sci; 2003 Feb; 94(2):200-4. PubMed ID: 12708497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.
    Nihei Y; Suga Y; Morinaga Y; Ohishi K; Okano A; Ohsumi K; Hatanaka T; Nakagawa R; Tsuji T; Akiyama Y; Saito S; Hori K; Sato Y; Tsuruo T
    Jpn J Cancer Res; 1999 Sep; 90(9):1016-25. PubMed ID: 10551333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
    Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
    Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.
    Kudoh S; Takada M; Masuda N; Nakagawa K; Itoh K; Kusunoki Y; Negoro S; Matsui K; Takifuji N; Morino H
    Jpn J Cancer Res; 1993 Feb; 84(2):203-7. PubMed ID: 8385085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
    Perez EA; Hack FM; Webber LM; Chou TC
    Cancer Chemother Pharmacol; 1993; 33(3):245-50. PubMed ID: 8269606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
    Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
    Fujita F; Fujita M; Sakamoto Y; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the mechanism of increased antitumor activity of UFT after combined treatment with CDDP].
    Oie S; Okabe H; Takeda S; Yamada Y
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1321-6. PubMed ID: 2114826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
    Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y
    Clin Cancer Res; 2009 Jul; 15(13):4348-55. PubMed ID: 19509138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].
    Yamada Y; Saito H; Oie S; Takechi T; Nakano K; Takeda S
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1327-31. PubMed ID: 2114827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
    Singhal SS; Singhal J; Yadav S; Dwivedi S; Boor PJ; Awasthi YC; Awasthi S
    Cancer Res; 2007 May; 67(9):4382-9. PubMed ID: 17483352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
    Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
    Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
    Tsunoda T; Tanimura H; Hotta T; Tani M; Iwahashi M; Ishimoto K; Tanaka H; Matsuda K; Yamaue H
    J Surg Oncol; 2000 Jan; 73(1):6-11. PubMed ID: 10649271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between cisplatin and gemcitabine in vitro and in vivo.
    Peters GJ; Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Braakhuis BJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):72-9. PubMed ID: 7481849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of cisplatin and etoposide in combination on small cell lung cancer cell lines.
    Kondo H; Kanzawa F; Nishio K; Saito S; Saijo N
    Jpn J Cancer Res; 1994 Oct; 85(10):1050-6. PubMed ID: 7961107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
    Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice].
    Fujita F; Fujita M; Fujita M; Sakamoto Y
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2595-601. PubMed ID: 7979419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.